Timber Pharmaceuticals Has Agreed To Be Acquired By LEO Pharma For Up To $36M Including An Initial Upfront Consideration Of $14M And Up To An Additional $22M In Contingent Value Rights
Portfolio Pulse from Benzinga Newsdesk
Timber Pharmaceuticals has agreed to be acquired by LEO Pharma for up to $36M, including an initial upfront consideration of $14M and up to an additional $22M in contingent value rights.
August 21, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Timber Pharmaceuticals is to be acquired by LEO Pharma for up to $36M. The deal includes an initial upfront consideration of $14M and up to an additional $22M in contingent value rights.
The acquisition of Timber Pharmaceuticals by LEO Pharma is a significant event for the company. The deal, which includes an upfront payment of $14M and up to an additional $22M in contingent value rights, could have a positive impact on the company's stock price in the short term as it provides a cash infusion and potential future payments.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100